ROYAL BANK OF CANADA - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 71 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$16,000
-73.8%
3,238
-43.2%
0.00%
Q4 2019$61,000
+96.8%
5,699
+90.0%
0.00%
Q3 2019$31,000
-34.0%
3,000
-1.5%
0.00%
Q2 2019$47,000
+20.5%
3,047
+1.4%
0.00%
Q1 2019$39,000
+34.5%
3,004
+0.1%
0.00%
Q4 2018$29,000
-53.2%
3,000
-20.3%
0.00%
Q3 2018$62,000
+24.0%
3,766
+19.8%
0.00%
Q2 2018$50,000
+8.7%
3,144
+4.7%
0.00%
Q1 2018$46,000
-16.4%
3,003
-14.2%
0.00%
Q4 2017$55,000
-1.8%
3,500
-31.2%
0.00%
Q3 2017$56,000
+93.1%
5,089
+63.9%
0.00%
Q2 2017$29,000
-9.4%
3,104
-17.2%
0.00%
Q1 2017$32,000
-25.6%
3,747
-6.0%
0.00%
Q4 2016$43,0003,985
+6030.8%
0.00%
Q4 2015$0
-100.0%
65
-90.4%
0.00%
Q3 2015$6,000
-40.0%
679
-23.9%
0.00%
Q2 2015$10,000892
+11050.0%
0.00%
Q4 2014$0
-100.0%
8
-85.5%
0.00%
Q3 2013$2,000550.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
VHCP Management II, LLC 315,980$3,381,0001.62%
VHCP Management, LLC 135,420$1,449,0001.56%
Eventide Asset Management 851,400$9,110,0000.59%
CARL DOMINO INC 26,000$278,0000.30%
SABBY MANAGEMENT, LLC 357,806$3,829,0000.22%
Telemetry Investments, L.L.C. 25,016$268,0000.15%
J. Goldman & Co LP 199,886$2,139,0000.14%
BAILARD, INC. 123,785$1,324,0000.12%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 94,945$1,015,0000.07%
Candriam S.C.A. 244,000$2,611,0000.06%
View complete list of STEMLINE THERAPEUTICS INC shareholders